Sm Russell, Te Angell, Mg Lechner, Dj Liebertz, Aj Correa, Uk Sinha, N Kokot, Al Epstein
{"title":"头颈部鳞状细胞癌的免疫细胞浸润模式和存活率。","authors":"Sm Russell, Te Angell, Mg Lechner, Dj Liebertz, Aj Correa, Uk Sinha, N Kokot, Al Epstein","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study examines the tumour-host immune interactions in head and neck squamous cell carcinoma (HNSCC) and their relationship to human papillomavirus (HPV) infectivity and patient survival.</p><p><strong>Methods: </strong>The adaptive and innate immune profile of surgical tumour specimens obtained from HNSCC patients was determined using qRT-PCR and immunohistochemistry. Intratumoural and invading margin leukocyte populations (CD3, CD8, CD16, CD20, CD68, FoxP3 and HLA-DR) were quantified and compared with patient disease-specific survival. Additionally, the expression of 41 immune activation- and suppression-related genes was evaluated in the tumour microenvironment. Tumour cells were also assessed for expression of HLA-A, HLA-G and HLA-DR. HPV infectivity of tumour biopsies was determined using HPV consensus primers (MY09/MY11 and GP5+/GP6+) and confirmed with p16 immunohistochemistry.</p><p><strong>Results: </strong>HPV<sup>+</sup> patient samples showed a significantly increased infiltration by intratumoural CD20<sup>+</sup> B cells, as well as by invasive margin FoxP3<sup>+</sup>Treg, compared with HPV<sup>-</sup> patient samples. There was also a trend towards increased intratumoural CD8<sup>+</sup> T cells and HLA-G expression on tumour cells in HPV<sup>+</sup> samples. qRT-PCR data demonstrated a general pattern of increased immune activation and suppression mechanisms in HPV<sup>+</sup> samples. Additionally, a combined score of intratumoural and invasive margin FoxP3 infiltration was significantly associated with disease-specific survival (<i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>These data demonstrate significant differences in the immune cell profile of HPV<sup>+</sup> and HPV<sup>-</sup> HNSCC. This study identifies several possible targets for immunotherapy and possible prognostic markers (FoxP3 and HLA-G) that may be specific to HNSCC.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":"5 3","pages":"24"},"PeriodicalIF":0.0000,"publicationDate":"2013-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979926/pdf/nihms542675.pdf","citationCount":"0","resultStr":"{\"title\":\"Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma.\",\"authors\":\"Sm Russell, Te Angell, Mg Lechner, Dj Liebertz, Aj Correa, Uk Sinha, N Kokot, Al Epstein\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This study examines the tumour-host immune interactions in head and neck squamous cell carcinoma (HNSCC) and their relationship to human papillomavirus (HPV) infectivity and patient survival.</p><p><strong>Methods: </strong>The adaptive and innate immune profile of surgical tumour specimens obtained from HNSCC patients was determined using qRT-PCR and immunohistochemistry. Intratumoural and invading margin leukocyte populations (CD3, CD8, CD16, CD20, CD68, FoxP3 and HLA-DR) were quantified and compared with patient disease-specific survival. Additionally, the expression of 41 immune activation- and suppression-related genes was evaluated in the tumour microenvironment. Tumour cells were also assessed for expression of HLA-A, HLA-G and HLA-DR. HPV infectivity of tumour biopsies was determined using HPV consensus primers (MY09/MY11 and GP5+/GP6+) and confirmed with p16 immunohistochemistry.</p><p><strong>Results: </strong>HPV<sup>+</sup> patient samples showed a significantly increased infiltration by intratumoural CD20<sup>+</sup> B cells, as well as by invasive margin FoxP3<sup>+</sup>Treg, compared with HPV<sup>-</sup> patient samples. There was also a trend towards increased intratumoural CD8<sup>+</sup> T cells and HLA-G expression on tumour cells in HPV<sup>+</sup> samples. qRT-PCR data demonstrated a general pattern of increased immune activation and suppression mechanisms in HPV<sup>+</sup> samples. Additionally, a combined score of intratumoural and invasive margin FoxP3 infiltration was significantly associated with disease-specific survival (<i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>These data demonstrate significant differences in the immune cell profile of HPV<sup>+</sup> and HPV<sup>-</sup> HNSCC. This study identifies several possible targets for immunotherapy and possible prognostic markers (FoxP3 and HLA-G) that may be specific to HNSCC.</p>\",\"PeriodicalId\":49195,\"journal\":{\"name\":\"Head and Neck Optical Diagnostics Society\",\"volume\":\"5 3\",\"pages\":\"24\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-02-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979926/pdf/nihms542675.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Head and Neck Optical Diagnostics Society\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Head and Neck Optical Diagnostics Society","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma.
Purpose: This study examines the tumour-host immune interactions in head and neck squamous cell carcinoma (HNSCC) and their relationship to human papillomavirus (HPV) infectivity and patient survival.
Methods: The adaptive and innate immune profile of surgical tumour specimens obtained from HNSCC patients was determined using qRT-PCR and immunohistochemistry. Intratumoural and invading margin leukocyte populations (CD3, CD8, CD16, CD20, CD68, FoxP3 and HLA-DR) were quantified and compared with patient disease-specific survival. Additionally, the expression of 41 immune activation- and suppression-related genes was evaluated in the tumour microenvironment. Tumour cells were also assessed for expression of HLA-A, HLA-G and HLA-DR. HPV infectivity of tumour biopsies was determined using HPV consensus primers (MY09/MY11 and GP5+/GP6+) and confirmed with p16 immunohistochemistry.
Results: HPV+ patient samples showed a significantly increased infiltration by intratumoural CD20+ B cells, as well as by invasive margin FoxP3+Treg, compared with HPV- patient samples. There was also a trend towards increased intratumoural CD8+ T cells and HLA-G expression on tumour cells in HPV+ samples. qRT-PCR data demonstrated a general pattern of increased immune activation and suppression mechanisms in HPV+ samples. Additionally, a combined score of intratumoural and invasive margin FoxP3 infiltration was significantly associated with disease-specific survival (P < 0.05).
Conclusions: These data demonstrate significant differences in the immune cell profile of HPV+ and HPV- HNSCC. This study identifies several possible targets for immunotherapy and possible prognostic markers (FoxP3 and HLA-G) that may be specific to HNSCC.